Quest Selling And Marketing Expenses from 2010 to 2024

DGX Stock  USD 163.89  2.57  1.59%   
Quest Diagnostics Selling And Marketing Expenses yearly trend continues to be fairly stable with very little volatility. Selling And Marketing Expenses is likely to outpace its year average in 2024. During the period from 2010 to 2024, Quest Diagnostics Selling And Marketing Expenses regression line of annual values had r-squared of  0.14 and arithmetic mean of  16,420. View All Fundamentals
 
Selling And Marketing Expenses  
First Reported
2010-12-31
Previous Quarter
13.5 K
Current Value
18.8 K
Quarterly Volatility
K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Quest Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quest Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 265.1 M, Interest Expense of 99.3 M or Selling General Administrative of 1.5 B, as well as many indicators such as Price To Sales Ratio of 1.13, Dividend Yield of 0.0214 or PTB Ratio of 3.0. Quest financial statements analysis is a perfect complement when working with Quest Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Quest Diagnostics Correlation against competitors.

Latest Quest Diagnostics' Selling And Marketing Expenses Growth Pattern

Below is the plot of the Selling And Marketing Expenses of Quest Diagnostics Incorporated over the last few years. It is Quest Diagnostics' Selling And Marketing Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Quest Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Selling And Marketing Expenses10 Years Trend
Slightly volatile
   Selling And Marketing Expenses   
       Timeline  

Quest Selling And Marketing Expenses Regression Statistics

Arithmetic Mean16,420
Geometric Mean15,969
Coefficient Of Variation30.34
Mean Deviation2,661
Median15,000
Standard Deviation4,982
Sample Variance24.8M
Range20.5K
R-Value(0.37)
Mean Square Error23.1M
R-Squared0.14
Significance0.17
Slope(412.14)
Total Sum of Squares347.4M

Quest Selling And Marketing Expenses History

202418.8 K
202313.5 K
201115 K
201034 K

About Quest Diagnostics Financial Statements

Quest Diagnostics investors use historical fundamental indicators, such as Quest Diagnostics' Selling And Marketing Expenses, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Quest Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Selling And Marketing Expenses13.5 K18.8 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Quest Stock Analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.